SINGAPORE (Reuters) -Shares of European drugmakers slipped on Friday after U.S. President Donald Trump sent letters to major ...

The announcement of a 15% tariff on pharmaceutical imports to the U.S. from the European Union may have not been the ideal ...

Global stocks weakened on Friday after Donald Trump hit dozens of countries with tariffs, as the US president pushed ahead ...

U.S. President Donald Trump sent letters to the chief executives of 17 major pharmaceutical companies, urging immediate ...

President Donald Trump said his administration would “deploy every tool” to get drug prices reduced from large pharmaceutical ...

Trump posted individual letters he sent 17 drugmakers, including Eli Lilly, GSK, Pfizer, Regeneron, Merck, Pfizer and Novo ...

As pharmaceutical import tariffs take shape in Europe, President Donald Trump is rounding out the week by spotlighting ...

President Trump on Thursday sent letters to 17 of the world’s largest drug companies, telling them to take more steps to ...

President Donald Trump called out 17 Big Pharma CEOs over "exorbitant" drug pricing in individual letters sent out Thursday, ...

Trump signed an Executive Order May 12 directing the administration to take action to bring drug prices charged in the U.S.

Sanofi SNY reported second-quarter 2025 adjusted earnings of 90 cents per American depositary share, which missed the Zacks ...

A global stock selloff extended to a sixth day - the longest losing streak since September 2023 - after President Donald Trump boosted tariffs for imports from across the world.